SEARCH

SEARCH BY CITATION

References

  • 1
    Brodeur GM, Maris JM. Neuroblastoma. In PizzoPA, PoplackDG eds. Principles and practice of pediatric oncology. Philadelphia: Lippincott-Raven 2001; 895937.
  • 2
    Ribatti D, Vacca A, Dammacco F. The role of the vascular phase in solid tumor growth: a historical review. Neoplasia 1999; 1; 293302.
  • 3
    Ribatti D, Scavelli C, Roccaro AM, Crivellato E, Nico B, Vacca A. Hamatopoietic cancer and angiogenesis. Stem Cells Dev. 2004; 13; 484495.
  • 4
    Ribatti D, Marimpietri D, Pastorino F et al. Angiogenesis in neuroblastoma. Ann. NY Acad. Sci. 2004; 1028; 133142.
  • 5
    Ara T, Fukuzawa M, Kusafuka T et al. Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: association with tumour progression and clinical outcome. J. Pediatr. Surg. 1998; 33; 12721278.
  • 6
    Meister B, Grunebach F, Bautz F et al. Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma. Eur. J. Cancer 1999; 35; 445449.
  • 7
    Eggert A, Ikegaki N, Kwiatkowski J, Zhao H, Brodeur GM, Himelstein BP. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin. Cancer Res. 2000; 6; 19001908.
  • 8
    Meitar D, Crawford SE, Rademaker AW, Cohn SL. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J. Clin. Oncol. 1996; 14; 405414.
  • 9
    Canete A, Navarro S, Bermudez J, Pellin A, Castel V, Llombart-Bosch A. Angiogenesis in neuroblastoma: relationship to survival and other prognostic factors in a cohort of neuroblastoma patients. J. Clin. Oncol. 2000; 18; 2734.
  • 10
    Katzenstein HM, Cohn SL, Crawford S, Meitar D. Angiogenesis in neuroblastoma. J. Clin. Oncol. 2000; 18; 27892791.
  • 11
    Ribatti D, Raffaghello L, Pastorino F et al. In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression. Int. J. Cancer 2002; 102; 351354.
  • 12
    Schuster SJ, Koury ST, Bohler M, Salceda S, Card J. Cellular sites of extrarenal and renal erythropoietin production in anemic rats. Br. J. Haematol. 1992; 81; 153159.
  • 13
    Lacombe C, Mateux P. Biology of erythropoietin. Haematologica 1998; 83; 724732.
  • 14
    Ribatti D, Vacca A, Roccaro AM, Crivellato E, Presta M. Erythropoietin as an angiogenic factor. Eur. J. Clin. Invest. 2003; 33; 891896.
  • 15
    Anagnostou A, Liu Z, Steiner M et al. Erythropoietin receptor mRNA expression in human endothelial cells. Proc. Natl Acad. Sci. USA 1994; 91; 39743978.
  • 16
    Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc. Natl Acad. Sci. USA 1990; 87; 58785982.
  • 17
    Ashley RA, Dubuque SH, Dvorak B, Woodward SS, Williams SK, Kling PJ. Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells. Pediatr. Res. 2002; 51; 472478.
  • 18
    Carlini RG, Reyes AA, Rothstein A. Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int. 1995; 47; 740748.
  • 19
    Ribatti D, Presta M, Vacca A et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 1999; 93; 26272636.
  • 20
    Witthuhn BA, Quelle FW, Silvennoinen O et al. JAK-2 associates with erythropoietin receptor is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993; 74; 227236.
  • 21
    Jaquet K, Krause K, Tawakol-Khodai M, Geidel S, Kuch KM. Erythropoietin and VEGF exhibit angiogenic potential. Microvasc. Res. 2002; 64; 326333.
  • 22
    Brodeur GM, Pritchard J, Berthold F et al. Revision of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J. Clin. Oncol. 1993; 11; 14661477.
  • 23
    Horak ER, Leek R, Klenk N et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992; 340; 11201124.
  • 24
    Vacca A, Ribatti D, Roncali L et al. Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer 1993; 72; 455461.
  • 25
    Ribatti D, Nico B, Vacca A et al. Do mast cells help to induce angiogenesis in B-cell non Hodgkin's lymphoma? Br. J. Cancer 1998; 77; 19001906.
  • 26
    Kayser K, Gabius HJ. Analysis of expression of erythropoietin-binding sites in human lung carcinoma by the biotinylated ligand. Zentrabl. Pathol. 1992; 138; 266270.
  • 27
    Westenfelder C, Baranowski RL. Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney Int. 2000; 58; 647657.
  • 28
    Yasuda Y, Musha T, Tanaka H et al. Inhibition of erythropoietin signalling destroys xenografts of ovarian and uterine cancers in nude mice. Br. J. Cancer 2001; 84; 836843.
  • 29
    Yasuda Y, Fujita Y, Masuda S et al. Erythropoietin is involved in growth and angiogenesis in malignant tumors of female reproductive organs. Carcinogenesis 2002; 23; 17971805.
  • 30
    Acs G, Zhang PJ, McGrath CM et al. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am. J. Pathol. 2003; 162; 17891806.
  • 31
    Batra S, Perelman N, Luck LR, Shimada H, Malik P. Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival. Lab. Invest. 2003; 83; 14771487.
  • 32
    Hengartner MO, Horvitz HR. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 1994; 76; 665676.
  • 33
    Acs G, Zhang PJ, Rebbeck TR, Acs P, Verna A. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Cancer 2002; 95; 969981.
  • 34
    Arcasoy MO, Amin K, Karayal AF et al. Functional significance of erythropoietin receptor expression in breast cancer. Lab. Invest. 2002; 82; 911918.
  • 35
    Dillard DG, Venkatraman G, Cohen C, Delgaudio J, Gal AA, Mattox DE. Immunolocalization of erythropoietin and erythropoietin receptor in vestibular schwannoma. Acta Otolaryngol. 2001; 121; 149152.
  • 36
    Yasuda Y, Fujita Y, Matsuo T et al. Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis 2003; 24; 10211029.